Tenderwize
Retour à la recherche

Open house discount agreements for Secukinumab

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 132 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Secukinumab, ATC L04AC10

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

The buyer reserves the right to replace open-house contracts with exclusive contracts from separate tenders, which woul...

No estimated value or volume guarantees; actual uptake depends on prescribing behavior and number of participants.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Feb 28, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Supply of Secukinumab (ATC L04AC10) pharmaceutical products
  • Enter into non-exclusive discount agreements with AOK Rheinland-Pfalz/Saarland
Afficher le résumé complet

Open House non-exclusive discount agreement for Secukinumab (ATC L04AC10) by AOK Rheinland-Pfalz/Saarland. The procedure is open for all interested pharmaceutical companies to enter into discount contracts under uniform conditions. The contract term is max 24 months starting 01.05.2025, with rolling entry on the first of each month. The notice explicitly states it is not a public procurement under EU directive 2014/24/EU.

Risques

The buyer reserves the right to replace open-house contracts with exclusive contracts from separate tenders, which woul...

No estimated value or volume guarantees; actual uptake depends on prescribing behavior and number of participants.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Only authorized and marketable drugs in Germany may be supplied
  • For drugs not yet in Lauer-Taxe: provide AMIce database extract with proof of authorization and marketability

Administrative

  • Submission of signed contract documents

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria specified; this is an open-house model with no selection.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open house discount agreements for Secukinumab

Non-exclusive discount contracts for Secukinumab (ATC L04AC10). All interested pharmaceutical companies can participate under uniform terms. Contracts are non-exclusive and may be replaced by exclusive contracts from separate tenders. Maximum duration 24 months from earliest start date (01.05.2025).

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria specified; this is an open-house model with no selection.

Date limite

Deadline Feb 28, 2027

Détails de la procédure

Date de publication
12 Mar 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
162068-2025

Documents (1)

Appels d'offres similaires